ACLA Welcomes Adam R. Borden as Senior Vice President of Policy and Strategy

July 14, 2022 Categories: ACLA News, All News, ACLA Press Releases

Washington, D.C. – The American Clinical Laboratory Association (ACLA) today welcomed Adam R. Borden as Senior Vice President of Policy and Strategy. 

“Adam brings a broad array of experiences and a deep understanding of the health policy landscape that will be invaluable as we work to advance our policy priorities.” said Susan Van Meter, President of ACLA. “We are thrilled to welcome Adam to the team and know his leadership in this new role will be a great asset to our members.” 

As Senior Vice President of Policy and Strategy, Borden will be focused on developing and implementing the Association’s forward-looking policy agenda that supports innovation in clinical laboratory testing. He joins the ACLA team with a diverse career in health care and extensive knowledge and understanding of federal health policy, provider reimbursement, and the changing landscape of health care delivery in the United States. 

Prior to joining ACLA, Borden served as Vice President of Market Access and Reimbursement at Cleerly, Inc. He previously was the Senior Director of Policy and Reimbursement Strategy at Siemens Healthineers, where he led strategic efforts for all business areas including imaging, laboratory diagnostics, and digital products. During this time, he also served as Chair of the Reimbursement Committee at the Medical Imaging & Technology Alliance (MITA), and Chair of the Diagnostics Payment Work Group at AdvaMedDx. 

Borden is a member of the Advisory Board at the Cancer Support Community’s Cancer Policy Institute, and holds a Bachelor of Arts degree from Rutgers University and a Master of Health Administration degree from A.T. Still University of Health Sciences.


The American Clinical Laboratory Association (ACLA) is the national trade association representing leading laboratories that deliver essential diagnostic health information to patients and providers. ACLA members are at the forefront of driving diagnostic innovation to meet the country’s evolving health care needs and provide vital clinical laboratory tests that identify and prevent infectious, acute and chronic disease. ACLA works to advance the next generation of health care delivery through policies that expand access to lifesaving testing services.

Print page / Save as PDF